Table 4.4 Reported cases of laboratory-confirmed, hepatitis C (past or present) infection, by sex, race/ethnicity, age group, and positive lab tests — Emerging Infections Program (EIP), Hepatitis Surveillance Demonstration Sites, 2011

Print
Related Pages
Category
 CO
No. (%)		 CT
No. (%)		 MN
No. (%)		 NM
No. (%)		 NY
State
No. (%)		 NY
City
No. (%)		 OR
No. (%)		 San
Francisco
No. (%)		 Total
No. (%)
Sex
Female
 1030
(35.5)		 957
(33.0)		 649
(36.0)		 884
(31.8)		 2467
(35.8)		 3146
(36.0)		 1639
(36.4)		 526
(27.1)		 11298
(34.8)
Male
 1864
(64.3)		 1940
(66.9)		 1142
(63.4)		 1897
(68.2)		 4408
(63.9)		 5595
(64.0)		 2865
(63.6)		 1418
(72.9)		 21129
(65.1)
Unknown/Miss
 4
(0.1)		 1
(0.0)		 11
(0.6)		 0
(0.0)		 23
(0.3)		 8
(0.1)		 0
(0.0)		 0
(0.0)		 47
(0.1)
Race/Ethnicity*
AI / AN
 24
(0.8)		 5
(0.2)		 97
(5.4)		 46
(1.7)		 28
(0.4)		 0
(0.0 )		 63
(1.4)		 13
(0.7)		 276
(0.8)
API
 16
(0.6)		 25
(0.9)		 50
(2.8)		 3
(0.1)		 59
(0.9)		 171
(2.0)		 46
(1.0)		 72
(3.7)		 442
(1.4)
Black
 143
(4.9)		 311
(10.7)		 203
(11.3)		 12
(0.4)		 614
(8.9)		 927
(10.6)		 105
(2.3)		 366
(18.8)		 2681
(8.3)
White
 992
(34.2)		 1222
(42.2)		 737
(40.9)		 283
(10.2)		 2284
(33.1)		 667
(7.6)		 1964
(43.6)		 624
(33.1)		 8773
(27.0)
Hispanic
 323
(11.2)		 506
(17.5)		 40
(2.2)		 419
(15.1)		 434
(6.3)		 306
(3.5)		 87
(1.9)		 148
(7.6)		 2263
(7.0)
Other
 21
(0.7)		 5
(0.2)		 9
(0.5)		 0
(0.0)		 64
(0.9)		 287
(3.3)		 13
(0.3)		 37
(1.9)		 436
(1.3)
Unknown / Missing
1379
(47.6)		 824
(28.4)		 666
(37.0)		 2018
(72.6)		 3415
(49.5)		 6391
(73.1)		 2226
(49.4)		 684
(35.3)		 17603
(54.2)
Age group (yrs)
0-14
 11
(0.4)		 8
(0.3)		 5
(0.3)		 10
(0.4)		 12
(0.2)		 42
(0.5)		 5
(0.1)		 4
(0.2)		 97
(0.3)
15-24
 121
(4.2)		 143
(4.9)		 126
(7.0)		 363
(13.1)		 416
(6.0)		 298
(3.4)		 142
(3.2)		 34
(1.8)		 1643
(5.1)
25-39
 613
(21.2)		 597
(20.6)		 316
(17.5)		 923
(33.2)		 1337
(19.4)		 1629
(18.6)		 655
(14.5)		 242
(12.5)		 6312
(19.4)
40-54
 1198
(41.3)		 1218
(42.0)		 729
(40.5)		 938
(33.7)		 2352
(34.1)		 3035
(34.7)		 1980
(44.0)		 715
(36.8)		 12165
(37.5)
55+
 948
(32.7)		 932
(32.2)		 626
(34.7)		 547
(19.7)		 2753
(39.9)		 3744
(42.8)		 1719
(32.8)		 948
(48.8)		 12217
(37.6)
Missing
 7
(0.2)		 0
(0.0)		 0
(0.0)		 0
(0.0)		 28
(0.4)		 1
(0.0)		 3
(0.3)		 2
(0.2)		 40
(0.1)
Positive Laboratory Tests†
RIBA
 279
(9.6)		 94
(3.2)		 367
(20.4)		 U
(U)		 746
(10.8)		 1117
(12.8)		 300
(6.7)		 23
(1.2)		 2926
(9.0)
HCV RNA
 1574
(54.3)		 743
(25.6)		 1315
(73.0)		 U
(U)		 3664
(53.1)		 4357
(49.8)		 2036
(45.2)		 1294
(66.6)		 14983
(46.1)
Genotype
 695
(24.0)		 89
(3.1)		 626
(34.8)		 U
(U)		 1494
(22.6)		 2582
(29.5)		 656
(14.8)		 538
(27.7)		 6680
(20.6)
Anti-HCV and
s/co ratio
 1721
(59.4)		 2360
(81.4)		 534
(29.6)		 U
(U)		 3198
(46.4)		 7001
(80.0)		 1155
(25.6)		 1250
(64.3)		 17219
(53.0)
Total new
reported cases
 2,898 2,898 1,802 2,781 6,898 8,749 4,504 1,944 32,474
Estimated 2010
population
 5,116,796 3,580,709 5,344,861 2,082,224 11,220,287 8,244,910 3,871,859 812,826 40,274,472
Rate per 100,000 population
 57 81 34 134 61 106 116 239 81

*Categorized in the following order: 1) Hispanic; 2) AI/AN; 3) API; 4) Black; 5) White; 6) Other;
† Cases can be reported with more than one laboratory test result
U=No data available for reporting.